Aurobindo launches atazanavir capsules
Aurobindo Pharma has launched atazanavir capsules 100 mg, 150 mg, 200 mg and 300 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.
Latest
Rite Aid reports fiscal 2019 first quarter results
Ahead of the August 9 shareholders vote on the proposed merger with Albertsons, Rite Aid Corp. reported operating results for its first fiscal quarter ended June 2, 2018. For the first quarter, the company reported net loss from continuing operations of $41.7 million, or $0.
Pharmacy groups file brief in Medicaid lawsuit
The National Association of Chain Drug Stores (NACDS), the Washington State Pharmacy Association (WSPA) and the National Community Pharmacists Association (NCPA) filed a legal brief this week with the Washington State Court of Appeals, challenging the state’s refusal to reimburse community pharmacie
Albertsons offers increased access to Naloxone
Albertsons Cos. announced that more than 1,600 of its pharmacies across 21 states have pharmacists with the ability to independently provide naloxone, a medication used to reverse the impacts of an opioid overdose, and to educate patients and caregivers about its use.
Soleo Health selected by Genentech to provide two limited distribution drugs
Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drug
Rite Aid pharmacists in Idaho able to prescribe select medications
Rite Aid Corp. announced that starting Sunday, July 1, Rite Aid pharmacists at all locations in Idaho will be able to prescribe medications to treat select, common conditions, under the Pharmacist Prescriptive Authority Rule Docket 27-0104-1701 promulgated by the Idaho State Board of Pharmacy.
Kimberly-Clark reports progress to sustainability 2022 goals
Kimberly-Clark Corp. has reported its progress toward achieving its Sustainability 2022 strategy to create social, environmental and business value.
HeadBlade names Tom Wainman as new brand spokesperson
HeadBlade, a leader in HeadCare and developers of the ultimate head shaving razor, the HeadBlade MOTO, announced Tom Wainman, formerly a pitchman for Hair Club for Men, as its new spokesperson.
AcneFree and AARS team to help new generation of acne sufferers
AcneFree announces its support of the American Acne and Rosacea Society (AARS), a non-profit organization, as a part of its commitment to better educate the 21 million teenagers in the U.S. – approximately 80% of all teens – who suffer from acne and occasional breakouts.
Upsher-Smith featuring Platinum Pass at AHS meeting
Upsher-Smith Laboratories (Upsher-Smith) announced that it will be featuring Platinum Pass, the latest addition to the Access Pathways Program for Qudexy XR (topiramate) extended-release capsules at the 60th Annual Scientific Meeting of the American Headache Society (AHS), June 28 to July 1, in
MinuteClinic offering hepatitis A vaccine in Ohio following outbreak
MinuteClinic, the retail medical clinic of CVS Health, is encouraging unvaccinated Ohio residents to receive the hepatitis A vaccine following an increase in confirmed cases of the virus.
McKesson Ventures donates $10,000 to Meals on Wheels America
SAN FRANCISCO – McKesson Ventures, the venture capital arm of McKesson Corporation, announced that it has donated $10,000 to Meals on Wheels America on behalf of its former portfolio company Landmark Health, a leading provider of in-home, risk-based medical care.
FDA grants priority review to single-dose flu drug
Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral treatment for acute, uncomplicated influenza in people 12 years and older.
FDA approves first marijuana-based prescription drug
The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood.
Aurobindo receives FDA approval for ertapenem injection
Aurobindo Pharma announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market ertapenem injection 1 g/vial. Aurobindo’s ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz Injection.
Dove making a new mark in beauty imagery
Starting next month, Dove will be taking another step in ensuring beauty is a source of confidence and not anxiety with the launch of a ‘No Digital Distortion Mark’. The Mark will roll out across all branded content globally beginning in July with deodorant campaigns leading the initiative.